Study to Evaluate Switching From a Regimen Consisting of the Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (STR) to the Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate STR
Clinical trial NCT01286740 · COMPLETED
Trial details
- NCT number
- NCT01286740
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.